Latest debt-to-equity ratio
TriSalus Life Sciences Debt-to-equity ratio
Direct answer
TriSalus Life Sciences's debt-to-equity ratio is 525.59%.
The verified market snapshot reports 525.59%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free TriSalus Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 525.59%
Explore related company data
View TriSalus Life Sciences's market capitalizationView TriSalus Life Sciences's price-to-book ratioView TriSalus Life Sciences's dividend yieldView TriSalus Life Sciences's 52-week price rangeView TriSalus Life Sciences's revenue growthView TriSalus Life Sciences's profit marginView all TriSalus Life Sciences key metricsReturn to TriSalus Life Sciences profile